SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 7, 1996
DRUG GUILD DISTRIBUTORS, INC.
(Exact Name of Registrant as Specified in its Charter)
New Jersey 2-96510-NY 11-2269958
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification
incorporation) Number)
350 Meadowland Parkway, Secaucus, New Jersey 07094
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number,
including area code, (201) 348-3700
Item 5: OTHER EVENTS
On February 7, 1996, the Company's Board of Directors approved the signing
of a letter of intent to effect a merger between the Company and Neuman Health
Services, Inc. through the exchange of Neuman common stock for shares of the
Company's common stock. The proposed merger, which is subject to the
negotiation and execution of a definitive agreement, is intended to be accounted
for as a "pooling of interests" in accordance with Generally Accepted Accounting
Principles.
In addition, on February 7, 1996, the Company's Board of Directors elected
Alan Glenn to the office of President to fill the vacancy created by the
retirement of Roman Englander effective December 31, 1995. Alan Glenn had
previously been an Executive Vice President of the Company for more than the
previous five (5) years.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Dated: March 8, 1996
DRUG GUILD DISTRIBUTORS, INC.
By: /s/ Jay Reba
Jay Reba
Chief Financial and Accounting Officer
